Compare drug alternatives

Qulipta® Alternatives

Qulipta®

(Atogepant)
Qulipta
Prescription Only
Qulipta is a prescription medication that is used as a preventative treatment for episodic migraines. It is a tablet that is taken once daily. The most common side effects are fatigue, nausea, and constipation. Qulipta is FDA approved for the following indications: Migraine prevention.

Ubrelvy®

(ubrogepant)
Ubrelvy
Prescription Only
Ubrelvy is a medication that adults can use to treat acute migraine attacks. It works by blocking CGRP, a protein believed to contribute to migraine attacks by causing pain, blood vessel dilation, and inflammation. Ubrelvy is well-tolerated, with less than 5% of individuals reporting side effects such as nausea, somnolence, and dry mouth. Ubrelvy does not prevent migraines. Ubrelvy is FDA approved for the following indications: Migraine.

Dosage & Administration

Administration
Oral
Oral
Dosing
10 mg, 30 mg, or 60 mg once daily. Severe Renal Impairment or End-Stage Renal Disease: 10 mg once daily.
50 mg or 100 mg as needed. Maximum daily dose: 200 mg. Severe Hepatic or Severe Renal Impairment: 50 mg.
Latin Shorthand
10mg qd, 30mg qd or 60mg qd Renal Impairment: 10mg qd
50 mg PRN or 100 mg PNR. Severe Renal Impairment: 50mg.

Financial Assistance

Copay
$0
$0
Annual Cap
$6,000
Maximum savings of $50 per pill for up to 13 prescription fills.
Assistance Expiration
12 30-day prescription fills
13 prescription fills
Generics
No lower-cost generic available
No lower-cost generic available

Popular alternatives

Relevant Resources

Ubrelvy
Qulipta